Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Clinical trial NCT03732638 · COMPLETED
Trial details
- NCT number
- NCT03732638
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2019-12-10
- Enrollment
- 1590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.